Literature DB >> 21482444

Activated microglia proliferate at neurites of mutant huntingtin-expressing neurons.

Andrew D Kraft1, Linda S Kaltenbach, Donald C Lo, G Jean Harry.   

Abstract

In Huntington's disease (HD), mutated huntingtin (mhtt) causes striatal neurodegeneration which is paralleled by elevated microglia cell numbers. In vitro corticostriatal slice and primary neuronal culture models, in which neuronal expression of mhtt fragments drives HD-like neurotoxicity, were employed to examine wild type microglia during both the initiation and progression of neuronal pathology. As neuronal pathology progressed, microglia initially localized in the vicinity of neurons expressing mhtt fragments increased in number, demonstrated morphological evidence of activation, and expressed the proliferation marker, Ki67. These microglia were positioned along irregular neurites, but did not localize with mhtt inclusions nor exacerbate mhtt fragment-induced neurotoxicity. Prior to neuronal pathology, microglia upregulated ionized calcium binding adaptor molecule 1 (Iba1), signaling a functional shift. With neurodegeneration, interleukin-6 and complement component 1q were increased. The results suggest a stimulatory, proliferative signal for microglia present at the onset of mhtt fragment-induced neurodegeneration. Thus, microglia effect a localized inflammatory response to neuronal mhtt expression that may serve to direct microglial removal of dysfunctional neurites or aberrant synapses, as is required for reparative actions in vivo. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21482444      PMCID: PMC3135676          DOI: 10.1016/j.neurobiolaging.2011.02.015

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  83 in total

1.  Ultrastructural localization and progressive formation of neuropil aggregates in Huntington's disease transgenic mice.

Authors:  H Li; S H Li; A L Cheng; L Mangiarini; G P Bates; X J Li
Journal:  Hum Mol Genet       Date:  1999-07       Impact factor: 6.150

2.  Biochemical abnormalities and excitotoxicity in Huntington's disease brain.

Authors:  S J Tabrizi; M W Cleeter; J Xuereb; J W Taanman; J M Cooper; A H Schapira
Journal:  Ann Neurol       Date:  1999-01       Impact factor: 10.422

3.  Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.

Authors:  M DiFiglia; E Sapp; K O Chase; S W Davies; G P Bates; J P Vonsattel; N Aronin
Journal:  Science       Date:  1997-09-26       Impact factor: 47.728

4.  Huntingtin aggregate-associated axonal degeneration is an early pathological event in Huntington's disease mice.

Authors:  H Li; S H Li; Z X Yu; P Shelbourne; X J Li
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

5.  Microglia density decreases with age in a mouse model of Huntington's disease.

Authors:  Li Ma; A Jennifer Morton; Louise F B Nicholson
Journal:  Glia       Date:  2003-09       Impact factor: 7.452

6.  Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines.

Authors:  Alexander V Panov; Claire-Anne Gutekunst; Blair R Leavitt; Michael R Hayden; James R Burke; Warren J Strittmatter; J Timothy Greenamyre
Journal:  Nat Neurosci       Date:  2002-08       Impact factor: 24.884

7.  C1q enhances microglial clearance of apoptotic neurons and neuronal blebs, and modulates subsequent inflammatory cytokine production.

Authors:  Deborah A Fraser; Karntipa Pisalyaput; Andrea J Tenner
Journal:  J Neurochem       Date:  2009-11-16       Impact factor: 5.372

8.  Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells.

Authors:  Wen Yang; John R Dunlap; Richard B Andrews; Ronald Wetzel
Journal:  Hum Mol Genet       Date:  2002-11-01       Impact factor: 6.150

Review 9.  Normal huntingtin function: an alternative approach to Huntington's disease.

Authors:  Elena Cattaneo; Chiara Zuccato; Marzia Tartari
Journal:  Nat Rev Neurosci       Date:  2005-12       Impact factor: 34.870

10.  C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells.

Authors:  C A Ogden; A deCathelineau; P R Hoffmann; D Bratton; B Ghebrehiwet; V A Fadok; P M Henson
Journal:  J Exp Med       Date:  2001-09-17       Impact factor: 14.307

View more
  29 in total

Review 1.  Huntington's disease and the striatal medium spiny neuron: cell-autonomous and non-cell-autonomous mechanisms of disease.

Authors:  Michelle E Ehrlich
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

2.  Microglial depletion prevents extracellular matrix changes and striatal volume reduction in a model of Huntington's disease.

Authors:  Joshua D Crapser; Joseph Ochaba; Neelakshi Soni; Jack C Reidling; Leslie M Thompson; Kim N Green
Journal:  Brain       Date:  2020-01-01       Impact factor: 13.501

Review 3.  Role of Microglia in Neurological Disorders and Their Potentials as a Therapeutic Target.

Authors:  Li Du; Ying Zhang; Yang Chen; Jie Zhu; Yi Yang; Hong-Liang Zhang
Journal:  Mol Neurobiol       Date:  2016-11-09       Impact factor: 5.590

Review 4.  Microglia in the developing brain: a potential target with lifetime effects.

Authors:  G Jean Harry; Andrew D Kraft
Journal:  Neurotoxicology       Date:  2012-02-02       Impact factor: 4.294

5.  Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors.

Authors:  Andrea Crotti; Christopher Benner; Bilal E Kerman; David Gosselin; Clotilde Lagier-Tourenne; Chiara Zuccato; Elena Cattaneo; Fred H Gage; Don W Cleveland; Christopher K Glass
Journal:  Nat Neurosci       Date:  2014-03-02       Impact factor: 24.884

Review 6.  Innate immune activation in neurodegenerative disease.

Authors:  Michael T Heneka; Markus P Kummer; Eicke Latz
Journal:  Nat Rev Immunol       Date:  2014-07       Impact factor: 53.106

7.  IKKβ and mutant huntingtin interactions regulate the expression of IL-34: implications for microglial-mediated neurodegeneration in HD.

Authors:  Ali Khoshnan; Adam Sabbaugh; Barbara Calamini; Steven A Marinero; Denise E Dunn; Jung Hyun Yoo; Jan Ko; Donald C Lo; Paul H Patterson
Journal:  Hum Mol Genet       Date:  2017-11-01       Impact factor: 6.150

Review 8.  An in vitro perspective on the molecular mechanisms underlying mutant huntingtin protein toxicity.

Authors:  G Cisbani; F Cicchetti
Journal:  Cell Death Dis       Date:  2012-08-30       Impact factor: 8.469

Review 9.  Features of microglia and neuroinflammation relevant to environmental exposure and neurotoxicity.

Authors:  Andrew D Kraft; G Jean Harry
Journal:  Int J Environ Res Public Health       Date:  2011-07-20       Impact factor: 3.390

10.  Immunofluorescent spectral analysis reveals the intrathecal cannabinoid agonist, AM1241, produces spinal anti-inflammatory cytokine responses in neuropathic rats exhibiting relief from allodynia.

Authors:  Jenny L Wilkerson; Katherine R Gentry; Ellen C Dengler; James A Wallace; Audra A Kerwin; Megan N Kuhn; Alexander M Zvonok; Ganesh A Thakur; Alexandros Makriyannis; Erin D Milligan
Journal:  Brain Behav       Date:  2012-03       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.